Deep Track Capital, LP - 05 Nov 2025 SCHEDULE 13G Report for MoonLake Immunotherapeutics Class A ordinary share, par value $0.0001 per share (MLTX)

Filing Manager
Deep Track Capital, LP
Reporting Manager
Deep Track Capital, LP
Security
MoonLake Immunotherapeutics Class A ordinary share, par value $0.0001 per share
Symbol
MLTX
Shares outstanding
71,363,328 shares
Disclosed Ownership
4,610,071 shares
Ownership
6.5%
Form type
SCHEDULE 13G
Filing time
12 Nov 2025, 16:02:05 UTC
Date of event
05 Nov 2025
SEC
View on sec.gov

Reporting Managers (3)

Name Ownership Shares Owned sole voting power shared voting power Signature Title CIK
Deep Track Capital, LP 6.5% 4,610,071 0 4,610,071 /s/ David Kroin David Kroin, Managing Member of the General Partner of the Investment Adviser
Deep Track Biotechnology Master Fund, Ltd. 6.5% 4,610,071 0 4,610,071 /s/ David Kroin David Kroin, Director
David Kroin 6.5% 4,610,071 0 4,610,071 /s/ David Kroin David Kroin